Compounds > 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole
Page last updated: 2024-09-03

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and quinoxalines

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with quinoxalines in 1 studies

Compound Research Comparison

Studies
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Trials
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Recent Studies (post-2010)
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Studies
(quinoxalines)		Trials
(quinoxalines)		Recent Studies (post-2010) (quinoxalines)
682189,8876253,095

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barr, JD; Bevins, RA; Murray, JE; Reichel, CM1

Other Studies

1 other study(ies) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and quinoxalines

ArticleYear
Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine.
    Neuropharmacology, 2010, Volume: 58, Issue:8

    Topics: Animals; Benzazepines; Conditioning, Classical; Discrimination, Psychological; Extinction, Psychological; Generalization, Psychological; Isoxazoles; Ligands; Male; Nicotine; Nicotinic Agonists; Pyrrolidines; Quinoxalines; Rats; Rats, Sprague-Dawley; Varenicline

2010